With the explosion of biological data now available as a direct result of genome sequencing initiatives, use of commercial gene synthesis and pre-designed synthetic biology tools is becoming increasingly popular. We wanted to understand how molecular cloners feel about using synthetic biology tools as replacements for in-house methods such as cloning. So, in December 2013, we polled users of…

In October 2013, we polled users of protein analysis products in the U.S. to understand how, if at all, budget sequestration has affected their lab’s purchase of protein analysis products.  Results reveal that both non-profit and for-profit researchers are impacted by budget sequestration as approximately 56% of non-profit and 29% of for-profit respondents indicated budget sequestration has definitely affected…

What are the top bioinformatics concerns for researchers that perform next-generation sequencing? We wanted to understand their “top of mind” concerns and not prompt users with a list of potential answers from which to choose.  So, we asked over 400 scientists in government, private, commercial and academic labs in the United States, all involved in performing next generation sequencing,…

We set out to understand, at a top level, which life science suppliers are recognized in the industry for having the most flexible pricing options, for reagents and for instruments.  The questions posed to North American, European and Chinese audiences were:

Q. Which life science reagent supplier has the most flexible pricing options?

Q. Which life science instrument supplier…

We set out to understand, at a top level, which life science suppliers are recognized in the industry for having the most memorable advertising, for reagents and for instruments.  The questions posed to North American, European and Chinese audiences were:

Q. Which life science reagent supplier has the most memorable advertising?

Q. Which life science instrument supplier has the…

When was the last time your company produced a printed catalog? You might want to consider the effectiveness of a printed catalog for certain regions such as in China. In Apr 2013, we polled Chinese cell culture researchers regarding what catalogs they used in the last month to purchase life science research products and whether it was in print…

We asked 2,172 researchers around the world what they thought of the announcement that Thermo Fisher Scientific is acquiring Life Technologies.  Less than 24 hours after the announcement roughly half of the participants (49%) were aware of the news.  The fact that this news has spread this quickly is a testament to the considerable impact this merger is likely…

China remains an attractive market for life science tools suppliers capable of taking advantage…

In February 2013 we polled our panel of fluorescent imaging reagent users regarding their anticipated laboratory budget. Data reveals that commercial users anticipate a slight increase compared to academic users. As shown in the table, 24.1% of commercial users of fluorescent imaging reagents expect their budget to increase over the next 12 months, vs. 17.6% of academic users (a…

If you thought cell therapy had suffered too many setbacks in recent years and was stuck in neutral – think again. In a recent Percepta poll of 250 randomly selected life science researchers working in biotechnology and pharmaceutical companies more than 20% are involved in projects focused on allogeneic or autologous cell therapy and/or regenerative medicine. Even more surprising…